Keiko Wanaka

Frequency of Anti-Heparin-PF4 Complex Antibodies (HIT Antibodies) in Uremic Patients on Chronic Intermittent Hemodialysis

Takefumi Matsuo, Hiroko Kobayashi, Miyako Matsuo et al. · Pathophysiology of Haemostasis and Thrombosis · 2006 · 33 citations

Dialysis, Immunology, Dialysis Therapy +22

Development of Potent and Selective Plasmin and Plasma Kallikrein Inhibitors and Studies on the Structure-Activity Relationship.

Yoshio Okada, Yuko Tsuda, Mayako Tada et al. · Chemical and Pharmaceutical Bulletin · 2000 · 30 citations · Full text

Heparin-induced Thrombocytopenia in a Uremic Patient Requiring Hemodialysis

Takefumi Matsuo, Hitoshi Kusano, Keiko Wanaka et al. · Clinical and Applied Thrombosis/Hemostasis · 2007 · 30 citations

Dialysis, Heparin Flush, Thrombosis +19

Plasmin inhibitor reduces T-cell lymphoid tumor growth by suppressing matrix metalloproteinase-9-dependent CD11b+/F4/80+ myeloid cell recruitment

Makoto Ishihara, Chiemi Nishida, Yoshihiko Tashiro et al. · Leukemia · 2011 · 28 citations

Tumor Biology, Cancer Immunosurveillance, Immunology +7

Role of platelet factor 4–heparin complex antibody (HIT antibody) in the pathogenesis of thrombotic episodes in patients on hemodialysis

Hidetomo Nakamoto, Yoshihiro Shimada, Tatsuhiko Kanno et al. · Hemodialysis International · 2005 · 26 citations

Immunology, Platelet Pathobiology, Dialysis Therapy +21